Legend Biotech logo — Multinational biopharmaceutical company focused on discoveri...

Legend Biotech

Multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies

Founded 2014 United States Somerset, United States 2565 employees Unknown Total: $1.62B Biotechnology, Health Care +2

General Information

Company Name Legend Biotech
Founded Year 2014
Location United States Somerset, United States +5
Employees 2565
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Unknown
Social

Get notified when Legend Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Legend Biotech is demonstrating significant progress in its R&D pipeline with upcoming Phase 1 data presentations for investigational LB2501, highlighting continued innovation in cell therapies. Concurrently, the company launched 'Heroes in Practice' to enhance patient and physician engagement, indicating a strategic focus on community building alongside therapeutic development. These advancements are strongly supported by substantial capital raises, including a $350M private placement in May 2023, fueling its aggressive growth and commercialization efforts.

Signal Types
Funding Clinical Trial Progress Product Launch
Strategic Labels
Clinical Development Patient Engagement Capital Infusion
Next Move: Clinical Trials
·
Impact: 8/10
·
Ideal For: Biopharma Growth Equity — Commercial Stage

About Legend Biotech

Legend Biotech, founded in 2014, is a rapidly advancing multinational biopharmaceutical company headquartered in the United States. The company is focused on discovering and developing cutting-edge cell-based therapies to address critical health needs. Operating across vital sectors like Biotechnology, Health Care, and Life Sciences, Legend Biotech expertly navigates the complexities of the global healthcare industry.

With its corporate headquarters in Somerset, NJ, and manufacturing facilities strategically located in the United States, China, and Belgium, the company ensures a broad international footprint and streamlined operations. Recent funding activities include a significant $350.00M private placement VC investment secured in May 2023, underscoring investor confidence in its innovative pipeline and commercialization strategies.

Legend Biotech's commitment to leveraging cutting-edge technologies positions it as a compelling prospect for further investment, driven by a mission to yield impactful therapeutic advancements worldwide.

Taxonomy: Biopharmaceutical, Cell-Based Therapies, Cell Therapy, Chimeric Antigen Receptor T-cell (CAR-T), Natural Killer (NK) Cell-based Immunotherapy, Oncology, Manufacturing Facilities, Clinical-Stage Therapeutics, R&D, Novel Therapies, Multiple Myeloma Treatment, Autologous Cell Therapy, Allogeneic Cell Therapy, Advanced Technology Platforms

Services & Products

End-to-end Cell Therapy Development
Drug Discovery
Clinical Trials
Commercialization of Therapies
Scientific Research and Publications

Target Customers

Patients with Hematologic Malignancies Patients with Solid Tumors Healthcare Professionals Oncologists Biopharmaceutical Investors

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Private Placement Vc •••••• - 01 May 2023
Post Ipo Equity •••••• - 01 Jul 2022
Post Ipo Equity •••••• 1
Investor
01 May 2021
Series A •••••• - 01 Jun 2020

Legend Biotech Alternatives & Competitors

View All Alternatives
Legend Biotech vs

Your contract manufacturing partner; committed to the advancement of promising cellular therapies -...

1 employees
Biotechnology, Life Sciences
Legend Biotech vs
Kite Pharma
Kite Pharma United States

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

Acquired
4013 employees
Biotechnology, Health Care
Legend Biotech vs
Lentitek
Lentitek United Kingdom

Enabling the next generation of medicines

Seed
9 employees
Biotechnology, Health Care

FAQ About Legend Biotech

Multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies
Legend Biotech was founded in 2014.
Legend Biotech is headquartered in Somerset, United States.
Legend Biotech operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences.
Legend Biotech has approximately 2565 employees.
Legend Biotech has completed 4 funding rounds, raising a total of $1.62B. The latest funding stage is Unknown.
Legend Biotech offers: End-to-end Cell Therapy Development, Drug Discovery, Clinical Trials, Commercialization of Therapies, Scientific Research and Publications.
Top alternatives and competitors to Legend Biotech include Aspire Health Science, Kite Pharma, Lentitek, Be Biopharma, Kincell Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Legend Biotech and Aspire Health Science are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Legend Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy